Table 3 Body weight, serum glucose level, lipid profile, liver and kidney functions in control and obese groups without ZnSO₄ tretatment, low dose (15 mg) ZnSO₄ treatment, and high dose (30 mg) ZnSO₄ treatment in male rats.

Body weight (g)

313.4 ± 22.8^bc

300.6 ± 6.4^bc

289.4 ± 24.9^c

419.0 ± 8.2^a

324.3 ± 42.7^b

303.9 ± 20.4^b

Glucose (mg/dl)

92.7 ± 10.7^cd

93.7 ± 7.7^bcd

91.0 ± 6.6^cd

130.3 ± 3.5^a

94.2 ± 6.6^bcd

96.7 ± 9.8^bc

Lipid profile

 Lipids (mg/dl)

347.4 ± 19.1^b

347.9 ± 21.8^b

323.5 ± 25.4^bc

406.5 ± 22.6^a

355.7 ± 14.4^b

343.3 ± 16..2^bc

 Cholesterol (mg/dl)

97.0 ± 7.3^bc

97.7 ± 14.2^bc

99.0 ± 26.8^bc

129.0 ± 10.3^a

111.0 ± 28.0^ab

112.3 ± 13.6^ab

 Triglyceride (mg/dl)

94.7 ± 10.4^c

90.0 ± 18.2^c

90.7 ± 15.0^c

196.3 ± 17.3^a

157.3 ± 7.4^b

153.3 ± 12.0^b

Liver enzymes

 GOT (U/L)

167.3 ± 13.2^bcd

162.2 ± 13.6^cde

131.4 ± 13.0^ef

275.0 ± 57.1^a

199.2 ± 27.7^b

173.0 ± 10.7^bc

 GPT (U/L)

63.1 ± 4.1^b

48.9 ± 7.6^cd

47.0 ± 8.9^cde

93.1 ± 5.0^a

40.9 ± 5.4^ef

41.1 ± 5.8^def

Kidney functions

 Urea (mg/dl)

34.0 ± 2.0^e

37.3 ± 3.0^bcde

37.0 ± 4.3^cde

42.2 ± 2.6^a

38.3 ± 1.9^abcd

38.4 ± 2.1^abc

 Uric acid (mg/dl)

2.6 ± 0.4^e

3.0 ± 0.4^de

3.3 ± 0.5^cde

2.6 ± 0.4^e

3.3 ± 0.6^cde

3.4 ± 0.2^cd

 Creatinine (mg/dl)

0.6 ± 0.07^ab

0.7 ± 0.07^a

0.6 ± 0.06^ab

0.6 ± 0.05^ab

0.6 ± 0.07^ab

0.6 ± 0.08^ab